Nicholas Lydon and Novartis - Free people check

(1 - 6 from 7

)

Trio to Receive Lasker Award | HHMI

www.hhmi.org

14-Sept — HHMI investigators Brian Druker and Charles Sawyers will join Nicholas Lydon, formerly of Novartis, in receiving the Lasker~Debakey ... › news › trio-receive-lasker-award

The Truth About the Drug Companies: How They Deceive Us and What to...

books.google.de

Working with a scientist at Novartis, Nicholas Lydon, he obtained a small supply of several of the company's most promising inhibitors. He found that imatinib ...

Profiles of Drug Substances, Excipients and Related Methodology

books.google.de

BACKGROUND Imatinib was developed in the late 1990s by biochemist Nicholas Lydon, a former researcher for Novartis, and oncologist Brian Druker of ...

Glivec developer Brian Druker hails SC ruling

ehealth.eletsonline.com

Big Pharma found little support from the small guy on the street as the Indian Supreme Court's decision to reject patent claims of the drug maker Novartis for...

Indian Supreme Court to Hear Novartis "Patents Versus ...

www.corpwatch.org

21-Aug — Developed by Nicholas Lydon in the 1990s, imatinib mesylate is now marketed under the brand name Gleevec by Novartis. › article › indian-supreme-c...